208 related articles for article (PubMed ID: 9286243)
1. Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients.
Tari A; Hamada M; Kamiyasu T; Sumii K; Haruma K; Inoue M; Kishimoto S; Kajiyama G; Walsh JH
Dig Dis Sci; 1997 Aug; 42(8):1741-6. PubMed ID: 9286243
[TBL] [Abstract][Full Text] [Related]
2. Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients.
Tari A; Hamada M; Kamiyasu T; Fukino Y; Sumii M; Haruma K; Sumii K; Inoue M; Kajiyama G
J Gastroenterol; 1996 Apr; 31(2):167-70. PubMed ID: 8680534
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori, peptic ulcer disease and inhibition of gastric acid secretion.
Rune S
Digestion; 1992; 51 Suppl 1():11-6. PubMed ID: 1397740
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.
Gillen D; Wirz AA; Neithercut WD; Ardill JE; McColl KE
Gut; 1999 Apr; 44(4):468-75. PubMed ID: 10075952
[TBL] [Abstract][Full Text] [Related]
5. Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment.
el-Nujumi A; Williams C; Ardill JE; Oien K; McColl KE
Gut; 1998 Feb; 42(2):159-65. PubMed ID: 9536937
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.
Thomson AB; Keelan M; Lastiwka R; Appelman-Eszczuk S; Zuk L; Drozdowski L; Prentice A; Sinclair P
Dig Dis Sci; 2003 Oct; 48(10):2045-56. PubMed ID: 14627354
[TBL] [Abstract][Full Text] [Related]
7. Effect of synthetic prostaglandin E2 analog enprostil on omeprazole-induced hypergastrinemia and hyperpepsinogenemia.
Meijer JL; Crobach LF; Jansen JB; Lamers CB
Dig Dis Sci; 1994 Mar; 39(3):609-16. PubMed ID: 8131700
[TBL] [Abstract][Full Text] [Related]
8. Effect of plaunotol on hypergastrinemia induced by long-term omeprazole administration in humans.
Kaneko H; Mitsuma T; Nagai H; Harada M; Kotera H; Furusawa A; Morise K
Dig Dis Sci; 1995 Jan; 40(1):160-5. PubMed ID: 7821104
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
Kato S; Takeyama J; Ebina K; Naganuma H
Pediatrics; 1997 Jul; 100(1):E3. PubMed ID: 9200377
[TBL] [Abstract][Full Text] [Related]
10. Effect of enprostil on serum gastrin and pepsinogen A and C levels in patients on long-term treatment with omeprazole.
Meijer JL; Jansen JB; Biemond I; Kuijpers IJ; Lamers CB
Aliment Pharmacol Ther; 1994 Apr; 8(2):221-7. PubMed ID: 8038355
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment.
Gillen D; Wirz AA; McColl KE
Gastroenterology; 2004 Apr; 126(4):980-8. PubMed ID: 15057737
[TBL] [Abstract][Full Text] [Related]
12. Antral Helicobacter pylori infection, hypergastrinemia and peptic ulcers: effect of eradicating the organism.
Park SM; Yoo BC; Lee HR; Yoon JH; Cha YJ
Korean J Intern Med; 1993 Jan; 8(1):19-24. PubMed ID: 8268142
[TBL] [Abstract][Full Text] [Related]
13. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
14. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
17. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.
Labenz J; Tillenburg B; Peitz U; Idström JP; Verdú EF; Stolte M; Börsch G; Blum AL
Gastroenterology; 1996 Mar; 110(3):725-32. PubMed ID: 8608881
[TBL] [Abstract][Full Text] [Related]
19. Eradication of Helicobacter pylori restores elevation of serum gastrin concentrations in patients with end-stage renal disease.
Tokushima H; Tamura H; Murakawa M; Matsumura O; Itakura Y; Itoyama S; Mitarai T; Isoda K
Intern Med; 1998 May; 37(5):435-9. PubMed ID: 9652896
[TBL] [Abstract][Full Text] [Related]
20. [Optimization of the anti-Helicobacter therapy of peptic ulcer on the basis of modern methods of pharmacokinetic analysis].
Bezborodnyĭ SD
Klin Lab Diagn; 2000 Nov; (11):37-9. PubMed ID: 11486745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
